💊 AI generated drugs could hit pharmacies by 2030
Insilico CEO Alex Zhavoronkov predicts that the first fully AI-designed medicines could be approved within 5 to 6 years, and he’s confident his company will achieve this milestone first.
Insilico is currently developing over 40 drugs, with AI playing a pivotal role in the entire process, from conception to human trials. Unlike most pharmaceutical companies, Insilico’s AI system actively contributes to the drug development process. Notably, an AI-selected psoriasis drug from Takeda is currently undergoing final testing, demonstrating the impact of AI in drug discovery.
Get ready: your future pills might be prescribed by a doctor, but invented by an algorithm.
